Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
13:11 EDT 15 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
IRVINE, Calif., Aug. 15, 2012 /PRNewswire/ -- Antigen Discovery Inc. (ADi) today announced that it has received a Phase I Small Business Innovation and Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID) of the...
Other Sources for this Article
More From BioPortfolio on "Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
